Patent · US Active

Isolated oligonucleotides containing modified nucleotides

US11866773B2 · kind B2 · utility

0Cited by
25References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 15, 2021
Grant dateJan 9, 2024
Priority date
Expiry dateFeb 18, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/689
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Described and featured herein are isolated oligonucleotides containing, from 5′ to 3′, a nicking enzyme recognition sequence, at least 9 nucleotides that specifically bind a target nucleic acid molecule, and 2′ modified nucleotides. The isolated oligonucleotides may be used in compositions and methods for quantifying detection of a target oligonucleotide in a sample in real time. These methods are compatible with target oligonucleotides amplified using a Nicking and Extension Amplification Reaction (NEAR) reaction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.